<DOC>
	<DOCNO>NCT03008447</DOCNO>
	<brief_summary>E2006-A001-108 4-period crossover study design demonstrate mean change baseline postural stability ( worsen ) participant awaken approximately 4 hour postdose significantly less lemborexant zolpidem tartrate extend release follow single-dose administration bedtime .</brief_summary>
	<brief_title>Crossover Study Evaluate Effect Lemborexant Versus Placebo Zolpidem Postural Stability , Auditory Awakening Threshold , Cognitive Performance Healthy Subjects 55 Years Older</brief_title>
	<detailed_description />
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Healthy , nonsmoking female participant , age 55 year old , male participant , age 65 year old , time informed consent Regular sleep timing duration , per follow criterion : 1 . Regular time bed , 7 9 hour report Screening verify Sleep Diary Screening Period adaptation night time bed less 7 hour 9 hour 2 7 consecutive night record Sleep Diary 2 . Regular bedtime , define time participant attempt fall asleep , 22:00 01:00 regular waketime , define time participant get bed day , 05:00 09:00 report Screening verify Sleep Diary Screening Period adaptation night neither bedtime waketime outside permitted time windows 2 7 consecutive night Able detect 1000 Hertz ( Hz ) tone 20 decibel ( dB ) Able read English 8thgrade level Is female childbearing potential Note : All female consider childbearing potential unless postmenopausal ( define amenorrheic least 12 consecutive month , postmenopausal without know suspected cause ) , sterilize surgically ( i.e. , bilateral tubal ligation , total hysterectomy , bilateral oophorectomy , surgery least 1 month dose ) . A current diagnosis insomnia disorder , sleeprelated breathe disorder , periodic limb movement disorder ( PLMD ) , restless legs syndrome , circadian rhythm sleep disorder , narcolepsy , sleeprelated violent behavior , sleepdriving , sleepeating , symptom another parasomnia investigator 's opinion make participant unsuitable study Has subjective sleep onset latency ( sSOL ) &gt; 20 minute subjective wake sleep onset ( sWASO ) &gt; 60 minute 2 night report Sleep Diary Screening Period adaptation night Latency persistent sleep ( LPS ) longer 30 minute measure polysomnography ( PSG ) Baseline night Has sleep onset rapid eye movement ( REM ) period , define first epoch stage REM within 15 minute onset persistent sleep , measure PSG either adaptation night Baseline night ApneaHypopnea Index &gt; 15 Periodic Limb Movement Arousal Index &gt; 15 measure PSG adaptation night Comorbid nocturia result frequent need get bed use bathroom night History fracture due fall within past 5 year Evidence orthostatic hypotension Screening Use hearing aid clinically significant hearing loss Presence history Meniere 's disease , labyrinthitis , benign paroxysmal positional vertigo , recent vertigo cause , recent dizziness head injury Unable stand unaided minimum 2 minute At Screening , fail Romberg test clinical judgment investigator Significant vision loss inability read computer screen &lt; 80 lumen per square meter ( lux ) ambient illumination History drug alcohol dependency abuse within approximately previous 2 year positive urine drug screen Screening Baseline Selfreports consume 14 alcoholcontaining drink per week ( female ) 21 alcohol contain drink per week ( male ) Screening A prolonged QT/heart rate correct QT interval ( QTc ) ( QT interval correct Fridericia 's formula [ QTcF ] &gt; 450 millisecond [ m ] ) demonstrate repeat electrocardiogram ( ECG ) Screening ( repeat initial ECG indicate QTcF interval &gt; 450 m ) Any suicidal ideation Screening within 6 month Screening lifetime suicidal behavior Evidence clinically significant disease ( e.g. , cardiac , respiratory , gastrointestinal , renal , psychiatric neurological disease , malignancy basal cell carcinoma , chronic pain ) condition opinion investigator ( ) could affect participant 's safety interfere study assessment Used prohibit prescription overthecounter concomitant medication within 1 week 5 half life , whichever longer , Baseline night Scheduled surgery study Transmeridian travel across 3 time zone 2 week Baseline night , plan travel 3 time zone study Currently enrol another clinical trial use investigational drug device within 28 day 5 half life , whichever longer precede informed consent Hypersensitivity lemborexant zolpidem excipients Active viral hepatitis ( B C ) demonstrate positive serology Previous exposure lemborexant suvorexant</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>E2006</keyword>
	<keyword>postural stability</keyword>
	<keyword>auditory awaken threshold</keyword>
	<keyword>cognitive performance</keyword>
	<keyword>healthy participant</keyword>
</DOC>